Attached files
file | filename |
---|---|
EX-32.1 - EX-32.1 - EAGLE PHARMACEUTICALS, INC. | exhibit32110k2020.htm |
EX-31.2 - EX-31.2 - EAGLE PHARMACEUTICALS, INC. | exhibit31210k2020.htm |
EX-31.1 - EX-31.1 - EAGLE PHARMACEUTICALS, INC. | exhibit31110k2020.htm |
EX-23.2 - EX-23.2 BDO CONSENT - EAGLE PHARMACEUTICALS, INC. | exhibit232bdoconsent.htm |
EX-23.1 - EX-23.1 - EAGLE PHARMACEUTICALS, INC. | exhibit23110k2020.htm |
EX-10.30 - EX-10.30 FORM OF PSU MILESTONES - EAGLE PHARMACEUTICALS, INC. | exhibit1030formofpsumilest.htm |
EX-10.29 - EX-10.29 FORM OF PSU TSR - EAGLE PHARMACEUTICALS, INC. | exhibit1029formofpsutsr.htm |
10-K - 10-K - EAGLE PHARMACEUTICALS, INC. | egrx-20201231.htm |
Exhibit 21.1
Subsidiaries of Eagle Pharmaceuticals, Inc.
Name of Subsidiary | Jurisdiction of Incorporation | ||||
Eagle Biologics, Inc. (formerly Arsia Therapeutics, Inc.) | Delaware | ||||
Eagle Research Lab Limited | Malta |